MEDTECH — Gain on sale of security
Business Segments · Gain on sale of securityAnalysis
StatementSegment
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ3 2025
Last reportedQ3 2025
How to read this metric
An increase indicates successful divestment of assets or favorable market conditions for the segment's investment portfolio.
Detailed definition
This metric captures the profit realized from the sale of investment securities held by the medical technology segment....
Peer comparison
Reported by companies with significant investment portfolios or venture arms within their segments.
Metric ID:
jnj_segment_medtech_gain_on_sale_of_securityHistorical Data
1 periods
| Q3 '25 | |
|---|---|
| Value | $200.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — gain on sale of security?
- Johnson & Johnson (JNJ) reported medtech — gain on sale of security of $200.00M in Q3 2025.
- What does medtech — gain on sale of security mean?
- Profit earned from selling investment securities held by the medical technology division.